ROMANIA - Advent backs Romanian pharma bolt-on
Advent International's Central & Eastern European team has done its third deal of the year with the bolt-on of Ozone Laboratories to its Romanian pharmaceuticals business LaborMed. Advent has provided additional equity to fund the deal, which includes the Ozone brand as well as its portfolio of products, which produced a turnover of EUR 44m in 2008. The deal does not include any of Ozone's companies.
More on Expansion
The Bolt-Ons Digest - 26 May 2023
Unquote’s selection of the latest add-ons with H&F's TeamSystem, Nordic Capital's Regnology, 3'i's Dutch Bakery and more
Baird Capital invests in Freemarket
GP’s growth capital investment in UK-based fintech platform marks seventh deal from Fund II
BGF makes GBP 19m minority investment in Brompton Bicycle
Transaction marks London-based foldable bike manufacturer’s first capital raise to accelerate international growth
The Bolt-Ons Digest – 17 April 2023
Unquote’s selection of the latest add-ons with Triton's BFC Group, Seven2's Groupe Crystal, Palatine's FourNet and more
Latest News
Carlyle acquires Meopta
GP plans to support Czech-American optical products manufacturer’s international expansion
Bugaboo backer Bain strolls back to market for H2 2022 launch
Sale of pram maker was initially launched last year but did not proceed due to credit market and consumer sector concerns
Officine Maccaferri sees Cinven and Triton go head-to-head
Italy-based geotechnical and soil erosion control business could be valued at EUR 700m-EUR 800m
Adams Street secures USD 3.2bn for newest secondaries programme amid LP stakes dealflow uptick
Private markets investor has seen LP stakes increase as a proportion of its deployment over the past year, partner Jeff Akers said